Skip to main

Post-Transplant Malignancy: Treatments

Post-Transplant Malignancy: Treatments

Learn more about post-transplant cancer, cancer therapies, and comprehensive integrated cancer and transplant clinics.

  • 2:00 PM - 3:00 PM EDT
  • Virtual, as part of AST's T3 webinar series.

Objectives:

After participating in this webinar, the attendee will be able to:

  1. Update knowledge on the epidemiology of post-transplant cancer.
  2. Illustrate examples of comprehensive, integrated cancer and transplant clinic.
  3. Review the updated data on cancer therapies for post-transplant cancers (e.g. immunotherapy and cellular therapies).

Speakers:

  • Naoka Murakami, MD, PhD, FAST • Assistant Professor, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA
  • Chris Blosser, MD, FAST • Professor, University of Washington, Fred Hutch Cancer Center and Seattle Children’s Hospital, Seattle, WA

Moderator:

  • Kenar Jhaveri, MD • Professor in Medicine, Northwell Health, New Hyde Park, NY

The AST Education Committee would like to thank the Thoracic and Critical Care Community of Practice (TCC COP), Kidney Pancreas Community of Practice (KPCOP), Liver and Intestinal Community of Practice (LICOP) and others for suggesting the core topic of "Post-Transplant Malignancy" as part of the 2023-2024 T3 webinar series. Learn more about AST's COPs at www.www.myast.org/cops .

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi